 Prospective trial comparing the efficacy and safety of CryoBalloonAblation CBA to standardized medication for treatment of early onset persistent atrial fibrillation AF without structural heart disease. The value of CBA in these patients has never been studied; the endpoints for persistent patients are much easier than for paroxysmal patients. Reduction in left atrial LA size will be compared versus patients on drug therapy and versus failing patients. 